ondansetron has been researched along with Hospital-Acquired Condition in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peltz, G | 1 |
| Südhof, TC | 1 |
1 other study available for ondansetron and Hospital-Acquired Condition
| Article | Year |
|---|---|
The Neurobiology of Opioid Addiction and the Potential for Prevention Strategies.
Topics: Analgesics, Opioid; Humans; Iatrogenic Disease; Neurobiology; Ondansetron; Opioid-Related Disorders; | 2018 |